Evidence map›Paper›PMID 25197007›Full record

ArticleAngewandte Chemie (International ed. in English)2014

Forazoline A: marine-derived polyketide with antifungal in vivo efficacy.

Thomas P Wyche, Jeff S Piotrowski, Yanpeng Hou, Doug Braun, Raamesh Deshpande, Sean McIlwain, Irene M Ong, Chad L Myers, Ilia A Guzei, William M Westler and 2 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Primed for Discovery.Biochemistry · 2024
    Review
  5. Review
  6. Review
  7. Anti-Candidal Marine Natural Products: A Review.Journal of fungi (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Metabolites · 2020
    Article
  19. Antimicrobial compounds from marine actinomycetes.Archives of pharmacal research · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Thomas P WychePharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI 53705 (USA).
Jeff S Piotrowski
Yanpeng Hou
Doug Braun
Raamesh Deshpande
Sean McIlwain
Irene M Ong
Chad L Myers
Ilia A Guzei
William M Westler
David R Andes
Tim S Bugni

Funding

Metabolomics driven discovery of drug leads from symbiotic bacteriaU19AI109673 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, CURRIE, CAMERON ROBERT · 2014 to 2018
$16.2M
WATER DISTRIB:PHYSICAL PROPERT:PIZZA &LMPS MOZZARELLA CHEESES:EARLY STAGE MATURP41RR002301 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 1985 to 2011
$13.0M
Mapping the reference genetic network of a eukaryotic cellR01HG005853 · NHGRI · UNIVERSITY OF TORONTO · PI ANDREWS, BRENDA JEAN, BOONE, CHARLES · 2010 to 2025
$7.6M
900 MHz NMR Spectrometer Biomolecular InvestigationsP41GM066326 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN L · 2002 to 2006
$5.0M
Methods for large-scale analysis of chemical-genetic interactionsR01HG005084 · NHGRI · UNIVERSITY OF MINNESOTA · PI MYERS, CHAD L · 2010 to 2022
$2.9M
Omics approaches for natural products discoveryR01GM104192 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BUGNI, TIMOTHY S · 2013 to 2019
$2.0M
Sparse Structural Equation Models for Gene Networks and Chemical GenomicsR01GM104975 · NIGMS · UNIVERSITY OF MIAMI CORAL GABLES · PI CAI, XIAODONG · 2012 to 2016
$1.8M
Rapid Screening and Dereplication of Marine Symbiotic Natural ProductsR01GM092009 · NIGMS · UNIVERSITY OF UTAH · PI SCHMIDT, ERIC W · 2010 to 2012
$1.1M
WIDE-BORE 9.4 TESLA NMR SPECTROMETER FOR UW-MADISONS10RR002781 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI MARKLEY, JOHN L · 1986 to 1986
–
CONSOLE UPGRADES FOR NMR FACILITYS10RR008438 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI MARKLEY, JOHN L · 1993 to 1993
–
ACQUISITION OF MASS SPECTROMETER FOR CORE FACILITYS10RR013790 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI RAINES, RONALD T · 1999 to 1999
–
NCRR NIH HHS P41 RR002301NCRR NIH HHS P41RR02301NCRR NIH HHS S10 RR002781NCRR NIH HHS S10 RR008438NCRR NIH HHS S10RR13790NHGRI NIH HHS 1R01HG005084-01A1NHGRI NIH HHS R01 HG005084NHGRI NIH HHS R01 HG005853NHGRI NIH HHS R01HG005853NIAID NIH HHS U19 AI109673NIGMS NIH HHS P41 GM066326NIGMS NIH HHS R01 GM092009NIGMS NIH HHS R01 GM104192NIGMS NIH HHS R01 GM104975PHS HHS 1R01M104975-01PHS HHS P41M66326
6 · The paper itself

Abstract

Forazoline A, a novel antifungal polyketide with in vivo efficacy against Candida albicans, was discovered using LCMS-based metabolomics to investigate marine-invertebrate-associated bacteria. Forazoline A had a highly unusual and unprecedented skeleton. Acquisition of (13)C-(13)C gCOSY and (13)C-(15)N HMQC NMR data provided the direct carbon-carbon and carbon-nitrogen connectivity, respectively. This approach represents the first example of determining direct (13)C-(15)N connectivity for a natural product. Using yeast chemical genomics, we propose that forazoline A operated through a new mechanism of action with a phenotypic outcome of disrupting membrane integrity.

Indexed as

AnimalsAntifungal AgentsBacteriaCandida albicansCarbon-13 Magnetic Resonance SpectroscopyMagnetic Resonance SpectroscopyMarine BiologyMass SpectrometryMiceMicrobial Sensitivity TestsMolecular StructurePolyketidesAntifungal Agentsforazoline APolyketidesantifungal agentsgenomicsnatural productsNMR spectroscopystructure elucidation

Identifiers

PMID25197007
PMCPMC4215405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.